These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22970186)

  • 21. Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections.
    Smet A; Martel A; Persoons D; Dewulf J; Heyndrickx M; Claeys G; Lontie M; Van Meensel B; Herman L; Haesebrouck F; Butaye P
    Microb Drug Resist; 2010 Jun; 16(2):129-34. PubMed ID: 20370505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli bacteremia.
    Park YS; Bae IK; Kim J; Jeong SH; Hwang SS; Seo YH; Cho YK; Lee K; Kim JM
    Yonsei Med J; 2014 Mar; 55(2):467-75. PubMed ID: 24532519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence of clonal groups O1:HNM-D-ST59, O15:H1-D-ST393, O20:H34/HNM-D-ST354, O25b:H4-B2-ST131 and ONT:H21,42-B1-ST101 among CTX-M-14-producing Escherichia coli clinical isolates in Galicia, northwest Spain.
    Mora A; Blanco M; López C; Mamani R; Blanco JE; Alonso MP; García-Garrote F; Dahbi G; Herrera A; Fernández A; Fernández B; Agulla A; Bou G; Blanco J
    Int J Antimicrob Agents; 2011 Jan; 37(1):16-21. PubMed ID: 21075606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subgrouping of ESBL-producing Escherichia coli from animal and human sources: an approach to quantify the distribution of ESBL types between different reservoirs.
    Valentin L; Sharp H; Hille K; Seibt U; Fischer J; Pfeifer Y; Michael GB; Nickel S; Schmiedel J; Falgenhauer L; Friese A; Bauerfeind R; Roesler U; Imirzalioglu C; Chakraborty T; Helmuth R; Valenza G; Werner G; Schwarz S; Guerra B; Appel B; Kreienbrock L; Käsbohrer A
    Int J Med Microbiol; 2014 Oct; 304(7):805-16. PubMed ID: 25213631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The emergence and dissemination of CTX-M-producing Escherichia coli sequence type 131 causing community-onset bacteremia in Israel.
    Karfunkel D; Carmeli Y; Chmelnitsky I; Kotlovsky T; Navon-Venezia S
    Eur J Clin Microbiol Infect Dis; 2013 Apr; 32(4):513-21. PubMed ID: 23117265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival in the environment is a possible key factor for the expansion of Escherichia coli strains producing extended-spectrum β-lactamases.
    Starlander G; Yin H; Edquist P; Melhus Å
    APMIS; 2014 Jan; 122(1):59-67. PubMed ID: 23755901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan.
    Komatsu Y; Kasahara K; Inoue T; Lee ST; Muratani T; Yano H; Kirita T; Mikasa K
    PLoS One; 2018; 13(8):e0202276. PubMed ID: 30157275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bloodstream infection with extended-spectrum beta-lactamase-producing Escherichia coli: The role of virulence genes.
    Hung WT; Cheng MF; Tseng FC; Chen YS; Shin-Jung Lee S; Chang TH; Lin HH; Hung CH; Wang JL
    J Microbiol Immunol Infect; 2019 Dec; 52(6):947-955. PubMed ID: 31076319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolates collected from diseased food-producing animals in the GERM-Vet monitoring program 2008-2014.
    Michael GB; Kaspar H; Siqueira AK; de Freitas Costa E; Corbellini LG; Kadlec K; Schwarz S
    Vet Microbiol; 2017 Feb; 200():142-150. PubMed ID: 27634182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Distribution of phylogenetic groups and virulence factors in CTX-M-15 β-lactamase-producing uropathogenic Escherichia coli strains isolated from patients in the community of Mérida, Venezuela].
    Millán Y; Hernández E; Millán B; Araque M
    Rev Argent Microbiol; 2014; 46(3):175-81. PubMed ID: 25444124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CTX-M-15-D-ST648 Escherichia coli from companion animals and horses: another pandemic clone combining multiresistance and extraintestinal virulence?
    Ewers C; Bethe A; Stamm I; Grobbel M; Kopp PA; Guerra B; Stubbe M; Doi Y; Zong Z; Kola A; Schaufler K; Semmler T; Fruth A; Wieler LH; Guenther S
    J Antimicrob Chemother; 2014 May; 69(5):1224-30. PubMed ID: 24398338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
    Peirano G; Costello M; Pitout JD
    Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features and molecular epidemiology of CMY-type beta-lactamase-producing Escherichia coli.
    Sidjabat HE; Paterson DL; Qureshi ZA; Adams-Haduch JM; O'Keefe A; Pascual A; Rodríguez-Baño J; Doi Y
    Clin Infect Dis; 2009 Mar; 48(6):739-44. PubMed ID: 19187027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.
    Chopra T; Marchaim D; Johnson PC; Chalana IK; Tamam Z; Mohammed M; Alkatib S; Tansek R; Chaudhry K; Zhao JJ; Pogue JM; Kaye KS
    Am J Infect Control; 2015 Jul; 43(7):719-23. PubMed ID: 25934068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance and phylogenetic background of extended spectrum β-lactamase producing Escherichia coli isolates from extra-intestinal infections.
    Chakraborty A; Adhikari P; Shenoy S; Saralaya V
    J Infect Public Health; 2015; 8(3):248-53. PubMed ID: 25466593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virulence factors profiles and ESBL production in Escherichia coli causing bacteremia in Peruvian children.
    Palma N; Gomes C; Riveros M; García W; Martínez-Puchol S; Ruiz-Roldán L; Mateu J; García C; Jacobs J; Ochoa TJ; Ruiz J
    Diagn Microbiol Infect Dis; 2016 Sep; 86(1):70-5. PubMed ID: 27345125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High prevalence of ST131 among CTX-M-producing Escherichia coli from community-acquired infections, in the Czech Republic.
    Papagiannitsis CC; Študentová V; Jakubů V; Španělová P; Urbášková P; Žemličková H; Hrabák J
    Microb Drug Resist; 2015 Feb; 21(1):74-84. PubMed ID: 25188031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients.
    Rodríguez-Baño J; Navarro MD; Romero L; Martínez-Martínez L; Muniain MA; Perea EJ; Pérez-Cano R; Pascual A
    J Clin Microbiol; 2004 Mar; 42(3):1089-94. PubMed ID: 15004058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergence of extended-spectrum β-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes.
    Park SH; Choi SM; Lee DG; Kim J; Choi JH; Kim SH; Kwon JC; Yoo JH
    Microb Drug Resist; 2011 Dec; 17(4):537-44. PubMed ID: 21875342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.